Unresectable/Metastatic Gastric Cancer
1 clinical trials · Condition
◉ Watch Unresectable/Metastatic Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer (NCT06365008) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
Track Unresectable/Metastatic Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.